Latest International Expansion News

Merino & Co. reported steady progress in Q2 FY26 with growing demand from China and ongoing investments in brand and manufacturing, despite a tightening cash position.

DTI Group has kicked off deliveries of ruggedised NVRs to Rio Tinto and secured multi-year maintenance contracts with major transit operators, signalling strengthened revenue streams and expansion in Europe.

Latrobe Magnesium has resolved a critical manufacturing defect at its Demonstration Plant, enabling Magnesium Oxide production to resume, while securing key financial support for its commercial expansion plans.

IODM Limited has reported a standout Q2 FY26 with record cash receipts driven by strong UK education sector growth and strategic board renewal.

Felix Group Holdings reported a robust 47% increase in total annual recurring revenue for Q2 FY26, driven by the strategic acquisition of Nexvia and expanding enterprise contracts. The company is advancing AI-powered platform enhancements and navigating key leadership transitions.

RocketBoots Limited has secured a transformative $9.1 million annual contract with a major multinational retailer, alongside a $7 million capital raise to accelerate its international growth strategy.

Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Spacetalk Ltd has completed a major pivot from hardware to a scalable software-as-a-service model, driving a 26% increase in active mobile subscribers and a 9% rise in annual recurring revenue to $12 million.

Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.

CurveBeam AI reported steady device orders alongside a $4 million milestone payment from its China commercialisation deal, while progressing FDA clearance and robotic surgery system validation.

Acrux Limited reports solid revenue growth and increased cash reserves in the December quarter, driven by expanding its topical generics portfolio in the US and strategic moves into female Hormone Replacement Therapy.